• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of fractalkine-CX3CR1for regulation of insulin resistance

Research Project

Project/Area Number 25860745
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Metabolomics
Research InstitutionKanazawa University

Principal Investigator

NAGASHIMADA Mayumi  金沢大学, 脳・肝インターフェースメディシン研究センター, 博士研究員 (30645510)

Project Period (FY) 2013-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2013: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Keywordsケモカイン / 慢性炎症 / インスリン抵抗性 / フラクタルカイン / CX3CR1 / 肥満 / fractalkine / マクロファージ / 脂肪組織
Outline of Final Research Achievements

The physiological and pathophysiological role of fractalkine and its receptor CX3CR1 in diseases are complex and not fully understood. In particular, it is not known how fractalkine-CX3CR1 can regulate obesity-associated chronic inflammation and metabolic diseases. Here, we investigated the role of fractalkine and CX3R1 system in obesity-induced inflammation and insulin resistance. We found that CX3CR1 deficient mice showed that insulin resistance, glucose intolerance, and hepatic steatosis in response to high fat (HF) feeding. These data suggested that fractalkine-CX3CR1 signal play a crucial role in development of insulin resistance. Further studies to clarify the mechanism by which fractalkine-CX3CR1 regulate inflammation and insulin resistance are going on.

Report

(3 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • Research Products

    (9 results)

All 2015 2014 2013 Other

All Journal Article (3 results) (of which Peer Reviewed: 3 results,  Open Access: 2 results,  Acknowledgement Compliant: 2 results) Presentation (5 results) Remarks (1 results)

  • [Journal Article] Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, beta-cryptoxanthin2015

    • Author(s)
      Ni Y, Nagashimada M, Zhan. L, Nagata N, Kobori M, Sugiura M, Ogawa K, Kaneko S, Ota T.
    • Journal Title

      Endocrinology

      Volume: 156 Issue: 3 Pages: 987-999

    • DOI

      10.1210/en.2014-1776

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice2014

    • Author(s)
      Kobori M, Ni Y, Takahashi Y, Watanabe N, Sugiura M, Ogawa K, Nagashimada M, Kaneko S, Naito S, Ota, T
    • Journal Title

      PLoS One

      Volume: 9 Issue: 5 Pages: e98294-e98294

    • DOI

      10.1371/journal.pone.0098294

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] GDNF signaling levels control migration and neuronal differentiation of enteric ganglion precursors2013

    • Author(s)
      Uesaka T, Nagashimada M, Enomoto H
    • Journal Title

      Journal of Neuroscience

      Volume: 33 Issue: 41 Pages: 16372-16382

    • DOI

      10.1523/jneurosci.2079-13.2013

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Presentation] Astaxanthin reduces hepatic insulin resistance and inhibits the progression of lipotoxic model of nonalcoholic steatohepatitis2015

    • Author(s)
      T Ota, Y Ni, N Nagata, M Nagashimada, S Kaneko
    • Organizer
      2015 Keystone Symposia Conference X8: Liver Metabolism and Nonalcoholic Fatty Liver Disease (NAFLD)
    • Place of Presentation
      Fairmont Chateau Whistler (ウィスラー カナダ)
    • Year and Date
      2015-03-23
    • Related Report
      2014 Annual Research Report
  • [Presentation] Lycopene attenuates the inflammatory adipose tissue response to high fat feeding by regulating both macrophage recruitment and M1/M2 status2014

    • Author(s)
      MAYUMI NAGASHIMADA, YINHUA NI, NAOTO NAGATA, LIANG XU, FEN ZHUGE, SHUICHI KANEKO, TSUGUHITO OTA
    • Organizer
      第50回欧州糖尿病学会議
    • Place of Presentation
      Reed Messe Vienna (ウィーン オーストリア)
    • Year and Date
      2014-09-16
    • Related Report
      2014 Annual Research Report
  • [Presentation] β-Cryptoxanthin Improves Hepatic Insulin Resistance And Inflammation Through M2 Dominant Shift Of Macrophages In Diet-induced Nonalcoholic Fatty Liver Disease2014

    • Author(s)
      TSUGUHITO OTA, YINHUA NI, MAYUMI NAGASHIMADA, FEN ZHUGE, NAOTO NAGATA, SHUICHI KANEKO
    • Organizer
      第74回アメリカ糖尿病学会
    • Place of Presentation
      Moscone Center (サンフランシスコ 米国)
    • Year and Date
      2014-06-16
    • Related Report
      2014 Annual Research Report
  • [Presentation] β-Cryptoxanthin improves hepatic insulin resistance through alternative activation of macrophages in lipotoxic NASH2014

    • Author(s)
      Yinhua Ni, 永島田まゆみ、長田直人、金子周一、太田嗣人
    • Organizer
      第57回日本糖尿病学会年次学術集会
    • Place of Presentation
      大阪国際会議場 (大阪府)
    • Year and Date
      2014-05-24
    • Related Report
      2014 Annual Research Report
  • [Presentation] β-cryptoxanthin improves hepatic insulin resistance and inflammation through alternative activation of macrophages in diet-induced nonalcoholic fatty liver disease

    • Author(s)
      M. Nagashimada, Y. Ni, F. Zhuge, N. Nagata, M. Kobori, M. Sugiura, S. Kaneko, T. Ota
    • Organizer
      第49回欧州糖尿病学会議 (EASD)
    • Place of Presentation
      Gran Via (スペイン)
    • Related Report
      2013 Research-status Report
  • [Remarks] 金沢大学 脳・肝インターフェースメディシン研究センター 細胞代謝栄養学

    • URL

      http://ota.w3.kanazawa-u.ac.jp/

    • Related Report
      2014 Annual Research Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi